BMS - Vakgroep PA (EN)

PUBLICATIONS PROF. DR. BäRBEL R. DORBECK-JUNG

87. Randles, S., Dorbeck-Jung, B., Lindner, R., Rip, A. Where to Next for Responsible Innovation?, in: Coenen. C. et al. Innovation and Responsibility: Engaging with New and Emerging Technologies. Akademische Verlagsgesellschaft Berlin 2014, p. 19-37.

86. Walhout, B., Kuhlmann, S., Randles, S & Dorbeck-Jung, B. Learning from de facto governance of Responsible Research and Innovation (RRI) - abstract and presentation for Eu-SPRI 2014 annual conference. Manchester, June 24-26, 2014 

85. Dorbeck-Jung, B., Transcending the myth of regulations’ stifling technological innovation- lessons from responsible drug innovation – abstract and presentation for ECPR Regulatory Governance Group conference. Barcelona, June 25-27, 2014.

84. Dorbeck-Jung, B., How can responsibilisation be enhanced in Responsible Research and Innovation governance? – abstract and presentation for SNet conference. Karlsruhe, September 21-23, 2014,

83. Dorbeck-Jung, B. Advantages of regulatory governance approach to nanomedical development, presentation for National Platform Nanomedicine. RIVM Bilthoven, November 28, 2014

82. Kuhlmann, S. Walhout, B. Dorbeck-Jung, B. Ordonez Matamoros, G. Facing the quest for Responsible Research & Innovation (RRI) - poster at STePS  research days 2014. Enschede, June 26-27, 2014

81. Discovering Specific Conditions for Compliance with Soft Regulation Related to Work with Nanomaterials. Nanoethics (2013), 83-92.

80. Meta-Regulation and Nanotechnologies: The Challenge of Responsibilisation Within the European Commission’s Code of Conduct for Responsible Nanosciences and Nanotechnologies Research. Nanoethics (2013) 7, 55-68 .

79. How can we characterize nano-specific soft regulation? Lessons from occupational health and safety governance. In: Konrad, K. et al. (eds.) , Shaping Emerging Technologies: Governance, Innovation, Discourse.Berlin-Amsterdam: Akademische Verlagsgesellschaft 2013, 83-102.

78. How technology governance mirrors the relation between law and innovation – transcending the myth of law’s stifling innovation. In: Colombi Ciacchi, A.L.B.  et al. (eds.) Law & Goverance. Beyond the Public-Private Divide? The Hague and Portland: Eleven International Publishing 2013, 163-185.

77. Responsive governance of uncertain risks in the European Union; Some lessons from nanotechnologies. In: Van Asselt, M. et al. (eds.), Trade, Health and the Environment. The European Union put to the test. Abingdon and New York: Routledge 2013, 113-132.

76. Conceptualization of the legitimacy of transnational technology regulation: First empirical insights from nanotechnology standardization, presented at: INTERNORM Interdisciplinary Workshop,University of Lausanne, Switzerland,19 March, 2013

75. How can we characterize nano-specific soft regulation? Lessons from occupational health and safety governance, presented at the American Law & Society Association’s Annual Conference, Boston 30 May – 2 June, 2013.

74. Conceptualization of the Legitimacy of Transnational Private Governance Arrangements Related to Technology Regulation, presented at the SNet Conference, Norheastern University, Boston, 27-29 October, 2013.

73. Governing RRI – What is the use of  (meta-) regulatory instruments for information provision?, presented at the SNet Conference, Norheastern University, Boston, 27-29 October, 2013.

72. How can regulation support beneficial nanotechnological development? Lessons from the case of nanomedicine, to be presented at the MicroNano Conference, Ede, 12 and 13 December, 2013.

71. Regulation of nanomaterials in the EU, in: W. Helwegen, L. Escoffier: Nanotechnology Commercialization for managers and scientists, Pan Stanford Publishing, Singapore, p. 355-372.

70. Nanotechnologische en medische regulering – wegwijzers voor de toekomst van het recht en de technische universiteit. Oratie, UTwente, Enschede, p. 1-30

69. Verantwoorde nanotechnologische innovatie, Nederlands Tijdschrift voor Natuurkunde, 79/7, p.244-246.

68. Exposure limits for nanomaterials – capacity and willingness of users to apply a precautionary approach, Journal of Occupational and Environmental Hygiene, Online: http://dx.doi.org/10.1080/15459624.2012.744253, p. 1-30 (with P. van Broekhuizen).

67. The Governance of therapeutic nanoproducts in the European Union - a model for new health technology regulation?, in: M. Flear, AM. Farrell, T. Hervewy & T. Murphy, European Law and New Health Technologies, OUP Oxford, p. 256-272 (in print).

66. ‘Stakeholder’s attitudes toward the European Code of Conduct for Nanosciences & Nanotechnologies’, Contribution to the Country Report “The Netherlands” (prepared by David Bennett and Serene Chi, Delft University of Technology, 2011.

65. ‘Is the European medical products authorization regulation equipped to cope with the challenges of nanomedicines?’ (with N. Chowdhury), Law & Policy 33(2), April 2011, 276-303.

64. ‘Governing Nanomedicine: Lessons from within, and for the EU medical technology regulatory framework.’(with D.M. Bowman, G. van Calster), ), Law & Policy 33(2), April 2011, 215-224.

63. ‘Contested hybridization of regulation: Failure of the Dutch regulatory system to protect minors from harmful media.’ Regulation & Governance, 4, 154-174 (with M.J. Oude Vrielink, J. Gosselt. J. van Hoof, D.T. de Jong).

62. ‘How can hybrid nanomedical products regulation cope with wicked governability problems’. In: Goodwin, M. et al (eds) Dimensions of Technology Regulation. Nijmegen: Wolf Publishers, 63-84.

61. ‘ De affaire Millecam: een ‘eye opener’voor rechtssociologisch onderwijs’. In: Doornbos, N. et al (eds) Rechtsspraak van buiten. Deventer: Kluwer, p. 145-150.

60. ‘Het klachtensysteem van de Kijkwijzer’. Tijdschrift voor Klachtrecht, 7, April 2010, 1-3 (with M.J. Oude Vrielink).

59. ‘Governing Nanomedicine: Learning from Regulatory Deficiencies of European Medical Technology Regulation’, Politeia XXV 94, 2009, 41-57.

58. ‘Global Trade. Changes in the Conceptualisation of Legal Certainty?’, in: V. Gessner: Contractual certainty in international trade, Oxford: Hart Publishing, 2009, 289-312.

57. ‘Openbaarmaking in het toezicht’, Bestuurskunde 18(2), 2009, 95-104 (with J. van Erp en M.J. Oude Vrielink).

56. ‘Politieke en publieke verantwoording in een stelsel van co-regulering’, in: H. van Duivenboden et. al (red.) Verbonden verantwoordelijkheden in het publieke domein, Den Haag: Lemma, 2009, 253-268 (with M.J. Oude Vrielink, M. de Jong en J. van Hoof).

55. Horen, zien en verkrijgen. Een onderzoek naar het functioneren van de zelfreguleringssystemen Kijkwijzer en PEGI (Pan European Game Information), Den Haag: Boom, 2009 (with J. F. van Gosselt, J.J. van Hoof, M.D.T. de Jong en M.F. Steehouder).

54. Security applications for converging technologies, Impact on the constitutional state and the legal order. Boom: Den Haag, 2008 (with W.B. Teeuw, A.H. Vedder, B.H.M. Custers).

53. ‘How can hybrid nanomedical products regulation cope with wicked governability problems?’, Conference Pre-proceedings, Tilburg, 10-11 December 2008, 45-55.

52. ‘The hardness of soft law in the United Kingdom: state and non-state regulatory conceptions related to nanotechnological development’, in: J. Verschuren en H. Schooten-van der Meer (eds.), The State Legislature and Non-State Law, Edward Elgar: Cheltenham, 2008, 129-150 (with M. van Amerom).

51. ‘Challenges to the legitimacy of international regulation: the case of pharmaceuticals standardization’, in: A. Follesdal, R. Wessel en J. Wouters (eds.): Multilevel regulation and the EU. The interplay between global, European and national normative processes, Nijhoff: Leiden, 2008, 51-71.

50. ‘What can prudent public regulators learn from the United Kingdom Government’s nanotechnological regulatory activities’, NanoEthics (1), 2007, 257-270.

49. ‘European ways of governing the marketing of pharmaceuticals – a shift towards more integration, better consumer protection and better regulation?’, in: V. Gessner and D. Nelken (eds.), European Ways of Law, Oxford: Hart Publishing, 2007, 279-304 (with M.J. van Heffen-Oude Vrielink).

48. Introduction to Special Issue Journal Recht der werkelijkheid, 2006, 5-8 (with M.J. van Heffen-Oude Vrielink).

47. ‘Op weg naar bruikbare overheidsregulering? Over de waarde van alternatieve wetgevingsconcepten en alternatieven voor overheidsregulering’, Special Issue Journal Recht der werkelijkheid, 2006, 9-18 (with M.J. van Heffen-Oude Vrielink).

46. ‘Het programma Bruikbare rechtsorde’, Special Issue Journal Recht der werkelijkheid, 2006, 19-31 (with M.J. van Heffen-Oude Vrielink).

45. ‘Op weg naar bruikbare overheidsregulering? Alternatieve wetgevingsconcepten en alternatieven voor overheidsregulering’, Special Issue Journal Recht der werkelijkheid, 2006, Elsevier (edited with M.J. van Heffen-Oude Vrielink).

44. ‘Kan zelfregulering regeldruk verminderen?’, Bestuurskunde 15(4), 2006, 7-13 (with M.J. van Heffen-Oude Vrielink).

43. ‘Do legal rules based on self-regulation affect the behaviour of doctors?’, in: N. Zeegers e.a. (eds.), Social and symbolic effects of legislation under the rule of law, Lewiston- New York, 2005, 203-219 (with M.J. van Heffen-Oude Vrielink).

42. ‘Zelfregulering en de wijze waarop artsen omgaan met medische dossiers’, in: Special Issue Journal Recht der werkelijkheid, 2005, 147-176 (with M.J. van Heffen-Oude Vrielink).

41. ‘De wetgevingsadvisering van de Raad van State – een fascinerend onderwerp van wetenschappelijk onderzoek’, Regelmaat 2, 2005, 60-68.

40. ‘Brauchbare Gesetzgebung in der aktuellen niederländischen Gesetzgebungspolitik’, Zeitschrift für Gesetzgebung 4, 2005, 342-357

39. ‘European ways of governing risks of pharmaceuticals – an effective approach to the protection of patient’s safety?’, Conference of the European Legal Sociology, Ońati, November 2005, published as CES Working Paper, Nijmegen (with M.J. van Heffen-Oude Vrielink).

38. Beelden over de wetgevingsadvisering van de Raad van State. Hoe wetgevingskwaliteit gemaakt wordt, Boom: Den Haag, 2003.

37. ‘Institutionalisierung von Wirkungskontrollen im niederländischen Gesetzgebungsprozess’, in: U. Karpen (ed.), Möglichkeiten einer Institutionalisierung der Wirkungskontrolle von Gesetzen, Nomos, Baden-Baden, 2003, 111-126.

36. ‘Zicht op wetgevingskwaliteit. Welke criteria achten leden van de Tweede Kamer de meest belangrijke kwaliteitseisen voor wetgeving?’, Regelmaat 4, 2003, 131-142.

35. ‘Legislating Interactively –Impact on the Institutions of the Democratic Legal State?’, American Law and Society Annual Conference, Budapest, Published as NIG Working Paper 1, 2001 (with A.Y. Kolkman).

34. ‘Legitimate Governance within the State’, in: H. Wagenaar (ed.), Government Institutions: Effects, Changes and Normative Foundations, Dordrecht-London, 2000, 109-127 (with H.M. de Jong).

33. ‘Overtuigende wetgevingskwaliteit’, in: B. van Klink en W. Witteveen (eds.), De overtuigende wetgever, Tjeenk Willink, 2000, 87-104.

32. ‘Opportunities and Limits of Institutional Autonomy in Public Universities – A Comparison of Governance Structure Regulation’, in: W. Berka e.a (eds.), Autonomy in education, Dordrecht-London, 2000, 111-147.

31. ‘Legisprudence. A Multidisciplinary Approach to the Creation and Evaluation of Legislation’, Associations 3, 1999, 211-235.

30. ‘Basics of Realistic Legisprudence’, Regelmaat 3, 1999, 141-151.

29. ‘Towards Reflexive Responsibility. New Ethics for Public Adminstration’, in: A. Hondeghem (ed.), Ethics and Accountability in a Context of Governance and New Public Administration, Amsterdam-Washington, 1998, 45-58.

28. ‘Een theoretisch kader voor de wetgevingstoetsing – op weg naar een responsieve wetgevingsleer’, Regelmaat 4, 1998, 198-209.

27. Juridische staatsleer, Bussum: Coutinho, 1997 (with H.M. de Jong).

26. ‘Setting Priorities in Dutch Legislative Policy’, in: P.B. Boorsma et al.. (eds.), Public Priority Setting: Rules and Costs, Dordrecht-London, 1997, 201-216.

25. ‘Comparing regulations of higher education quality evaluation’, European Journal of Education Law and Policy 1, 1997, 91-100.

24. ‘Comparative Legislative Studies’, in: Special Issue Archiv of Rechts- und Sozialphilosophie 69, 1995, 94-103.

23. ‘The conceptualization of comparative Educational Law’, in: De Groof (ed.), The Legal Status of Teachers in Europe, Leuven, 1995, 125-135.

22. ‘Correlations between Legal Rules of Quality Management and Mobility in Higher Education’, in: De Groof (ed.), The Legal Status of Teachers in Europe, Leuven, 1995, 105-114.

21. ‘Selbstregulierung im niederländischen Hochschulgesetz’, Zeitschrift für Gesetzgebung 2, 1995, 86-97.

20. ‘Wettelijk geconditioneerde zelfregulering; symbolisch concept of instrument met gevolgen?’, in Ph. Eijlander e.a. (eds.), Overheid en zelfregulering, Zwolle, 1993, 141-154.

19. Juridische aspecten van het GBA-project, Amsterdam: Cramwinckel, 1992 (with E.W.R. Brouwer en C. Prins).

18. ‘Elementen van reflexief recht in de WPR?’, in: N.J.H. Huls en H.D. Stout (eds.), Reflecties op reflexief recht, Zwolle, 1992, pp. 131-142.

17. ‘Zelfregulering en de eisen van de democratische rechtsstaat’, in: H.M. de Jong en J.J.A. Thomassen (eds.), Tussen overheid en samenleving, Enschede, 1991, 87-105.

16. ‘Datenschutz in den Niederlanden, aktuelle Entwicklungen im internationalen Vergleich’, Jahrbuch des Zentrums für Niederlande-Studien, Münster, 1990, 29-39.

15. ‘Informatietechnologie, wetgevingsconcepten en technology assessment’, Computerrecht 4, 1990, 181-185.

14. ‘Die niederländische Gesetzgebung zur Öffentlichkeit der Verwaltung’, Datenschutz und Datensicherung 8, 1990, 409-414.

13. ‘Das sozial-fiskalische Personenkennzeichen in der niederländischen Gesetzgebung’, Datenschutz und Datensicherung 4, 1989, 551-556.

12. ‘Informatiseringsrecht, een verkenning’, Computerrecht 2, 1987, 101-106.

11. ‘Die niederländische Gesetzgebung zum Gesundheitsdatenschutz’, Computer und Recht 9, 1987, 626-635.

10. ‘Informatiseringsrecht in het openbaar bestuur’, Tijdschrift voor openbaar bestuur 11, 1987, 1050-1055.

9. Datenverkehrsrecht und Datenschutz in der BRD und den Niederlanden, PhD thesis, 1985, Enschede: Febodruk.

8. ‘Verfahrensregelungen und Selbstregulierung der speichernden Stelle – rechtliche Lösungen van Datenschutzproblemen?’, in: W. Spiess e.a. (eds.), Datenschutz und Datensicherung im Wandel der Informationstechnologien, 1985, 250-256.

7. ‘Operationalisierung des Datenverkehrsrechts in Westeuropa’, Datenverarbeitung im Recht 3, 1984, 213-227.

6. ‘Datenschutz en Datenzugang der Forschung im Gesundheidsbereich’, in: W. Brennecke e.a (eds.), Datenquellen für Sozialmedizin und Epidemiologie, Berlin-New York, 1981, 37-50.

5. ‘Aspekte des Persönlichkeitsschutzes bei Gesundheidsinformationssystmen’, in: P. Möhr e.a.(eds.), Betriebliche Informationssysteme, Berlin-New York, 1980, 168-177.

4. ‘Ethische codes und forschungsspezifisches Datenschutzgesetz’, in: M. Kaase e.a. (eds.), Datenschutz und Datenzugang, Konsequenzen für die Forschung, Königstein, 1980, 248-254.

3. ‘Rechtliche und rechtspolitische Konsequenzen des Computereinsatzes in der Medizin’, ÖGI/GI-Konferenz, Linz, 1980.

2. ‘Data Protection in Medical Research’, MEDINFO, Tokyo, 1980.

1. ‘Datenschutz bei der Forschung mit Gesundheidsdaten’, Datenverarbeitung im Recht 3, 1979, 193-212.


Conference papers and lectures (selection)


45. Discovering specific conditions for compliance with soft regulation related to work with nanomaterials. Contribution to the ECPR Regulation and Governance Conference, Exeter, 27-29 June, (with A. Reichow)

44. Meta-regulation and nanotechnologies: the challenges of responsibilisation in case of the European Commission’s Code of Conduct, Paper submitted for S.NET 2012, Enschede 22-26 October, (with C. Shelley-Egan).

43. How to improve the evaluation of nanotechnology-related soft regulation? Lessons from a typology of nano-specific soft instruments on occupational health and safety. Paper submitted for S.NET 2012, Enschede 22-26 October, (with A. Reichow).

42. ‘Nano reference values and responsible governance – first results of the Pilot NRV’, Contribution to the international Workshop on NRVs, 29 September 2011, The Hague.

41. ‘Taking Corporate Responsibility Seriously: Nanomaterials, Occupational Safety and Voluntary Regulatory Tools’. Contribution to the international conference on the social economy.6 -8 July, Onati (Spain).

40. ‘How can de facto governance and regulatory pluralism contribute to the analysis of technology governance arrangements?’. Contribution to the Future of Science and Technology in Society Symposium in Honour of Arie Rip, 16 and 17 June 2011, University of Twente.

39. ‘Statement on the importance of benchmarks related to safe use of nanomaterials’, 4th Nano Safety for Success Dialogue, European Commission, 29 and 30 March 2011.

38. ‘Innovative regulation of therapeutic nanoproducts in the European Union’, Contribution to the Conference ‘European Law and New Health Technologies’, University of Manchester, 25 March 2011.

37. ‘Interdisciplinary challenges of nanomedicine’, Luch Lecture (together with Vinod Subramaniam), 50th Anniversary of the University of Twente, 9 March 2011.

36. ‘Nanotechnologie: technologische uitdagingen en impact op onze omgeving’, Keynote (together with Dave Blank, Conference Twents Meesterschap 2011, 20 and 21 January, University of Twente

35. ‘How can standardization and other forms of ‘soft’ regulation enhance responsible nanotechnological development?Contribution to the IGS/EU SPRI International Conference “Tentative governance in emerging science and technology”, 28-29 October 2010. UT.

34. ‘Current regulatory issues in nanomedicine’. Contribution to the Session on Regulation at the Annual Forum Conference of the ETP Nanomedicine, 14-15 October 2010. Milan.

33. ‘Emerging nanomedical regulation, Contribution to the Third Biennial Conference of the ECPR Regulatory Governance Group, 17-19 June 2010. Dublin (with N. Chowdhury).

32. ‘Lessons from regulatory governance of nanotechnologies: a responsive approach.’ Contribution to Ius Commune Conference “European Integration between trade and non trade”, 14, 15 March 2010 Maastricht.

31. ‘Nanopharmaceuticals and EU medical products regulation’, Contribution to Nanomed Round Table, Working Group on Regulation, Brussels, 14-15 September 2009.

30. ‘Drawing inspiration from European nanotechnological regulation’, Conference Complexity, Conflicts, Justice. 20 years of Sociology of Law, Ońati, 7-10 July 2009.

29. ‘Regulatory partnerships in nanobio product development’, EU Nano2life Working Group Workshop, Münster, 8 and 9 June 2009.

28. ‘Prudent conceptualization in the European Union’s nanotechnological risk regulation’, TG04 ‘Sociology of Risk and Uncertainty’ at the First ISA Forum on Sociology ‘Sociology and Public Debate’, Barcelona, 5-9 September 2008.

27. ‘Can co-regulation bridge the gap between nanotechnological promotion and control?’, (Re)Regulation in the Wake of Neoliberalism: Consequences of Three Decades of Privatization and Market Liberalization, Conference of the ECPR Standing Group Regulatory Governance, Utrecht, 5-7 June 2008.

26. ‘Governing nanomedicine – learning from European medical technology regulation’, submitted to Managing the uncertainty of nanotechnologies. Challenges to law, ethics and policy making, International Conference of the University of Padua, Rovigo, 22-23 May 2008.

25. ‘The hardness of soft law3 in nanotechnological governance,’ lecture University of Oxford, January 2008.

24. ‘Regulatory governance: lessons to be learned’, Paper submitted to the NIG Annual Working Conference, Tilburg, 8 November 2007 (with M.J. Oude Vrielink).

23. ‘What can new governance learn from transparency problems related to European pharmaceuticals regulation?’, Contribution to the American Law and Society Association/ European Research Committee Sociology of Law Conference, Berlin, 25-28 July 2007 (with M.J. Oude Vrielink).

22. ‘Challenges to Max Weber’s conceptualization of legal certainty in the era of economic globalization’, Paper submitted to the American Law and Society Association/ European Research Committee Sociology of Law Conference, Berlin, 25-28 July 2007.

21. ‘What can other governments learn from the United Kingdom’s regulatory activities related to nanotechnologies?’, Contribution to the Conference ‘Deliberating Future Technologies: Identity, Ethics and Governance of Nanotechnology’, University of Basel, 3-5 May 2007.

20. ‘Challenges to the legitimacy of pharmaceutical law – the case of the ICH’, Contribution to the CONNEX Seminar on Multilevel Regulation, NIAS, Wassenaar, 26-27 June 2006.

19. ‘EU ways of governing the marketing of pharmaceuticals – a shift towards more Europeanisation, better consumer protection and better regulation?’, Contribution to the American Law and Society Association Conference, Baltimore (US), 6-9 July 2006 (with M.J. Oude Vrielink).

18. ‘Economic globalization – changes in the conceptualization of legal certainty?’, Contribution to the Ońati Workshop “Legal Certainty beyond the State? Autonomous Structures in Globalized Exchange Processes”, 25-26 September 2006.

17. ‘Coping with the uncertainties of nanotechnology’s development – how can public regulation be developed in a process of mutual learning?’, Submitted to the ECPR/CRI Conference, Bath, 7-9 September 2006.

16. ‘Can self-regulation stop juridification?’, Contribution to the 3rd ECPR Conference, Budapest, 2005 (with M.J. van Heffen-Oude Vrielink).

15. ‘Prudent (Public) Regulating’, Annual Conference of the American Law and Society Association, Chicago, 2004.

14. ‘Do legal rules based on self-regulation affect behavior?’, Contribution to the Annual Conference of the American Law and Society Association, Pittsburgh, 2003 (with M.J. van Heffen-Oude Vrielink).

13. ‘Gesetzliche Wirkungskontrollen in den Niederlanden’, Symposium European Association of Legislation, Salzau, 2002.

12. ‘Commentaar op de Nota Wetgevingskwaliteitsbeleid en wetgevingsvisitatie’, Studiemiddag van de Vereniging voor Wetgeving, Den Haag, 2001.

11. ‘Evaluation of Legislation of the Dutch Council of the State’, Conference of the European Association of Legislation, Warschau, 2000.

10. ‘Brian Tamanaha’s Realistic Jurisprudence’, Symposium Tamanaha, Universiteit Tilburg, 2000.

9. ‘Deregulation’, European Group of Public Administration, Annual Conference, Athens, 1999 (with H.M. de Jong).

8. ‘Op weg naar een responsieve wetgevingsleer’, Contribution Conference Nederlandse Vereniging voor Wijsbegeerte van het recht, Amsterdam, 1998.

7. ‘Legitimate Governance in the State’, NIG Conference, 1998 (with H.M. de Jong).

6. ‘Realistic Legisprudence’, 4th Benelux-Scandinavian Symposium on Legal Theory, Turku (Finland), 1998.

5. ‘Philip Selznick and the Art of Legislating’, Conference of the UK Association for Legal and Social Philosophy, Edinburgh, 1997.

4. ‘Orebrö Lecture on Legisprudence and Responsive Legislation’, Lecture for the Universiteit of Orebrö (Sweden), 1997.

3. ‘Responsive regulation’, European Group of Public Administration, Annual Conference, Rotterdam, 1995.

2. ‘Comparative Aspects of Legisprudence’, IVR-conference, Bologna, 1994.

1. ‘Self-Regulation in Data Protection Laws, an Appropriate Solution?’, European Group of Public Administration, Annual Conference, Den Haag, 1991.